4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000079
Chief Medical Officer sold 7,000 shares at an average $111.84 ($782,882)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 36,218 | D |
| 2026-08-17 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 39,718 | D |
| 2026-08-17 | Sale : show line 3 in the form 10b5-1 | −900 | $109.65 | $98,687 | 38,818 | D |
| 2026-08-17 | Sale : show line 4 in the form 10b5-1 | −300 | $110.52 | $33,155 | 38,518 | D |
| 2026-08-17 | Sale : show line 5 in the form 10b5-1 | −3,320 | $112.01 | $371,886 | 35,198 | D |
| 2026-08-17 | Sale : show line 6 in the form 10b5-1 | −2,480 | $112.56 | $279,154 | 32,718 | D |
| Open-market sales · 7,000 sh · avg $111.84 · $782,882 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-17 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 197,063 | D |
| 2026-08-17 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 168,492 | D |
Loading xslF345X06/form4.xml…